Drugs / PF-00477736
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00437203 | Dec 2006 → Apr 2011 | neoplasm | Pfizer | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-00477736 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00437203 ↗ |
| Route | Intravenous | “PF-00477736 will be administered intravenously on Days 2 and 9” NCT00437203 ↗ |